Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
3.2%
0%
3.2%
6 Months
10.39%
0%
10.39%
1 Year
41.75%
0%
41.75%
2 Years
65.04%
0%
65.04%
3 Years
77.49%
0%
77.49%
4 Years
43.53%
0%
43.53%
5 Years
28.61%
0%
28.61%
Fresenius SE & Co. KGaA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-9.24%
EBIT Growth (5y)
-13.81%
EBIT to Interest (avg)
5.66
Debt to EBITDA (avg)
3.52
Net Debt to Equity (avg)
0.51
Sales to Capital Employed (avg)
0.95
Tax Ratio
35.76%
Dividend Payout Ratio
119.59%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
7.72%
ROE (avg)
8.80%
Valuation key factors
Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
1.47
EV to EBIT
17.06
EV to EBITDA
11.26
EV to Capital Employed
1.30
EV to Sales
1.67
PEG Ratio
0.04
Dividend Yield
2.10%
ROCE (Latest)
7.61%
ROE (Latest)
7.69%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot : Dec 2023
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 2 Foreign Institutions (0.1%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
5,581.00
5,651.00
-1.24%
Operating Profit (PBDIT) excl Other Income
822.00
890.00
-7.64%
Interest
86.00
81.00
6.17%
Exceptional Items
0.00
0.00
Consolidate Net Profit
345.00
471.00
-26.75%
Operating Profit Margin (Excl OI)
99.30%
111.10%
-1.18%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -1.24% vs 0.37% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is -26.75% vs 73.80% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
21,833.00
21,067.00
3.64%
Operating Profit (PBDIT) excl Other Income
3,040.00
2,737.00
11.07%
Interest
543.00
515.00
5.44%
Exceptional Items
-12.00
-69.00
82.61%
Consolidate Net Profit
867.00
288.00
201.04%
Operating Profit Margin (Excl OI)
84.10%
63.50%
2.06%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 3.64% vs -1.23% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 201.04% vs -76.43% in Dec 2023
About Fresenius SE & Co. KGaA 
Fresenius SE & Co. KGaA
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






